The Leading Innovations in Precision Oncology

With the promise of precision oncology becoming a reality, broad molecular profiling has now become standard of care for many cancer types – and is required for certain therapies. Molecular, genetic and immune profiling is now available to guide precise and individualized treatment decisions.

We incorporate comprehensive panels of molecular profiling which precisely analyzes DNA, RNA, protein biomarkers, immune biomarkers and functional tumor response testing, revealing the highest quality molecular blueprint for evidence-based selection of the most appropriate cancer therapy. In addition to comprehensive molecular profiling, we engage with tools such as innovated industry-leading artificial intelligence algorithms that predict patient responses to standard treatments, such as immunotherapy or chemotherapy, based on their personalized molecular profile.

Our molecular profiling options help:

• Navigate among therapies with potential benefit

• Identify therapies that may not have been considered

• Determine drugs with potential lack of benefit (avoiding unnecessary toxicities and costs)

• Match patients to clinical trials